The Molecular Mechanisms and Therapeutics in Multiple Sclerosis

Dear Colleagues,

Multiple sclerosis is a neuroinflammatory and neurodegenerative disease and the leading cause of neurological disability in young adults. More than 2 million patients are affected worldwide. In the last two decades, there has been unimaginable progress in treatment. While treatment options for relapsing MS are already well established, treatment options for progressive MS remain limited. The ultimate goal of curing MS has still not been achieved and will not be achievable for the foreseeable future.

The aim of this thematic collection of Biomolecules is to highlight recent findings in pathophysiology, histopathology, and their translation into therapeutic concepts. We encourage contributions on the latest immunological and pathophysiological findings, latest therapeutic concepts with special focus on progressive courses, and future therapeutic options. Studies dealing with biomarkers, in diagnostic and prognostic but also therapeutic areas, are also of particular interest.

Prof. Dr. Paulus Stefan Rommer
Prof. Dr. Uwe Klaus Zettl
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.